Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/9411
Title: Prevention of accelerated atherosclerosis by angiotensin-converting enzyme inhibition in diabetic apolipoprotein E-deficient mice.
Austin Authors: Candido, Riccardo;Jandeleit-Dahm, Karin A;Cao, Zemin;Nesteroff, Stefan P;Burns, Wendy C;Twigg, Stephen M;Dilley, Rodney J;Cooper, Mark E;Allen, Terri J
Affiliation: Department of Medicine, University of Melbourne, Austin and Repatriation Medical Centre, Heidelberg West, Australia
Issue Date: 9-Jul-2002
Publication information: Circulation; 106(2): 246-53
Abstract: Atherosclerosis is a major complication of diabetes, but the mechanisms by which diabetes promotes macrovascular disease have not been fully delineated. Although several animal studies have demonstrated that inhibition of ACE results in a decrease in the development of atherosclerotic lesions, information about the potential benefits of these agents on complex and advanced atherosclerotic lesions as observed in long-term diabetes is lacking. The aim of this study was to evaluate whether treatment with the ACE inhibitor perindopril affects diabetes-induced plaque formation in the apolipoprotein E (apoE)-deficient mouse.Diabetes was induced by injection of streptozotocin in 6-week-old apoE-deficient mice. Diabetic animals received treatment with perindopril (4 mg x kg(-1) x d(-1)) or no treatment for 20 weeks. Nondiabetic apoE-deficient mice were used as controls. Induction of diabetes was associated with a 4-fold increase in plaque area compared with nondiabetic animals. This accelerated atherosclerosis was associated with a significant increase in aortic ACE expression and activity and connective tissue growth factor and vascular cell adhesion molecule-1 expression. Perindopril treatment inhibited the development of atherosclerotic lesions and diabetes-induced ACE, connective tissue growth factor, and vascular cell adhesion molecule-1 overexpression in the aorta.The activation of the local renin-angiotensin system in the diabetic aorta and the reduction in atherosclerosis with ACE inhibitor treatment provides further evidence that the renin-angiotensin system plays a pivotal role in the development and acceleration of atherosclerosis in diabetes.
Gov't Doc #: 12105166
URI: https://ahro.austin.org.au/austinjspui/handle/1/9411
Journal: Circulation
URL: https://pubmed.ncbi.nlm.nih.gov/12105166
Type: Journal Article
Subjects: Actins.analysis
Angiotensin-Converting Enzyme Inhibitors.therapeutic use
Animals
Aorta.chemistry.metabolism.pathology
Apolipoproteins E.genetics
Arteriosclerosis.etiology.metabolism.pathology.prevention & control
Collagen.analysis
Connective Tissue Growth Factor
Diabetes Mellitus, Experimental.complications
Disease Progression
Growth Substances.biosynthesis.genetics
Immediate-Early Proteins.biosynthesis.genetics
Intercellular Signaling Peptides and Proteins
Male
Mice
Mice, Inbred C57BL
Mice, Knockout
Muscle, Smooth, Vascular.chemistry
Peptidyl-Dipeptidase A.genetics.metabolism
Perindopril.therapeutic use
Phagocytes.physiology
Proliferating Cell Nuclear Antigen.analysis
RNA, Messenger.biosynthesis
Vascular Cell Adhesion Molecule-1.biosynthesis.genetics
Appears in Collections:Journal articles

Show full item record

Page view(s)

20
checked on May 18, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.